Medical technology company Surgical Planning Associates (SPA) has introduced its US Food and Drug Administration (FDA)-approved HipInsight augmented reality (AR) intra-operative guidance system for joint arthroplasty.
Last month, the FDA granted 501(k) clearance to the SPA’s system.
The HipInsight system projects holograms on AR glasses that provide surgeons with X-ray vision to see inside the patient’s body.
SPA founder Dr Stephen Murphy said: “Traditional navigation systems, robotics, and interoperative imaging provide information on flat screens outside the surgeon’s view of the patient, leaving the process disjointed and awkward.
“The HipInsight system enables surgeons to stay focused on the patient, projecting holograms on AR glasses that effectively give them ‘X-ray vision,’ so that surgeons can see what they need to see when they need to see it right inside the patient’s body.”
It is the first FDA-cleared surgical guidance platform to be contained fully in a head-mounted device, Microsoft HoloLens 2.
By merging Cloud-based preoperative planning and virtual interoperative guidance, the platform helps surgeons to be more precise in the very critical aspects of the operation, improving the chances of successful outcomes.
Compared to the cumbersome and costly traditional robotic and navigation systems, the latest system offers a seamless and intuitive solution.
Dr Daniel Ward of Longwood Orthopedic Associates assisted Dr Murphy with the inaugural surgery.
Ward said: “It’s amazing to be able to actually see the entire bony anatomy, implants, and instruments inside the patient while you’re operating.
“This is the kind of technology surgeons have been striving for. When you try it for the first time, it’s just a mind-blowing experience.”